Avanos Medical Inc (AVNS)

Payables turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Cost of revenue (ttm)	US$ in thousands	306,500	300,800	299,100	294,600	310,500	335,200	351,400	367,900	370,900	366,800	368,500	381,100	380,300	379,900	376,100	352,600	341,500	325,500	312,000	308,300
Payables	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Payables turnover		—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

December 31, 2024 calculation

Payables turnover = Cost of revenue (ttm) ÷ Payables
= $306,500K ÷ $—K
= —

The payables turnover ratio for Avanos Medical Inc is not available for the period specified in the data provided. This ratio measures how efficiently a company is managing its accounts payable by comparing the cost of goods sold to the average accounts payable balance.

The absence of data for the payables turnover ratio restricts our ability to assess the company's ability to pay its suppliers promptly and effectively utilize its working capital. A higher payables turnover ratio typically indicates that the company is paying its suppliers quickly, which could be positive in terms of maintaining good supplier relationships. Conversely, a lower ratio may suggest that the company is taking longer to settle its payables, which can impact its liquidity and possibly indicate inefficiencies in managing its working capital.

Without the specific payables turnover ratio values, it is challenging to provide a more detailed analysis of how Avanos Medical Inc is performing in terms of managing its accounts payable. Monitoring this ratio over time can provide insights into the company's operational efficiency and supplier management practices.